Seaport Therapeutics, Inc.
SPTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002042347
In the last 90 days, Seaport Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 73 institutions reported holding it in 13F filings for Q3 2026, worth $766.9M in total; no superinvestor holds it.
SEC filings
10-K, 10-Q, 8-K, 20-F and 40-F reports Seaport Therapeutics, Inc. filed with the SEC, newest first.
Livermore lists each filing's form, 8-K items and dates only. To read a filing, open it on SEC.gov; an 8-K's press release or other attachments, such as exhibit 99.1 for Item 2.02, are in the filing index.
| Filed | Form | 8-K items | Period | Document | Filing index |
|---|---|---|---|---|---|
| Nov 2, 2026 | 10-Q | – | Sep 30, 2026 | SEC | Index |
| Nov 2, 2026 | 8-K | 2.029.01 | Nov 2, 2026 | SEC | Index |
| Aug 3, 2026 | 10-Q | – | Jun 30, 2026 | SEC | Index |
| Aug 3, 2026 | 8-K | 2.029.01 | Aug 3, 2026 | SEC | Index |
| Jun 8, 2026 | 10-Q | – | Mar 31, 2026 | SEC | Index |
| Jun 8, 2026 | 8-K | 2.029.01 | Jun 8, 2026 | SEC | Index |
| May 4, 2026 | 8-K | 5.039.01 | May 4, 2026 | SEC | Index |